GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
7AUW | Q9QXC1 | Inhibitory complex of human meprin beta with mouse fetuin-B. | |
8GYO | Q96RD7 | Inner channel lipids regulated gating mechanism of human pannexins. | |
5ZNS | H9J9M0 | Insect chitin deacetylase | Chitin deacetylase (E.C.3.5.1.41) |
5ZNT | H9J9M0 | Insect chitin deacetylase | |
1S78 | P04626 | Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex | |
1S78 | 1S78 | Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex | |
4DCH | P35557 | Insights into Glucokinase Activation Mechanism: Observation of Multiple Distinct Protein Conformations | |
5FQL | P22304 | Insights into Hunter syndrome from the structure of iduronate-2- sulfatase | IDURONATE-2-SULFATASE (E.C.3.1.6.13) |
7KD6 | 7KD6 | Insulin Receptor L1-CR plus alphaCT fragment in co-complex with Fv 83-7 and single-chain insulin SCI-b | |
7KD6 | P06213 | Insulin Receptor L1-CR plus alphaCT fragment in co-complex with Fv 83-7 and single-chain insulin SCI-b | |
6CE9 | P06213 | Insulin Receptor ectodomain in complex with two insulin molecules | Insulin receptor (E.C.2.7.10.1), Insulin receptor subunit alpha (E.C.2.7.10.1), Insulin A chain, Insulin B chain |
6CE9 | P01308 | Insulin Receptor ectodomain in complex with two insulin molecules | Insulin receptor (E.C.2.7.10.1), Insulin receptor subunit alpha (E.C.2.7.10.1), Insulin A chain, Insulin B chain |
6CE9 | P01318 | Insulin Receptor ectodomain in complex with two insulin molecules | Insulin receptor (E.C.2.7.10.1), Insulin receptor subunit alpha (E.C.2.7.10.1), Insulin A chain, Insulin B chain |
6CEB | P06213 | Insulin Receptor ectodomain in complex with two insulin molecules - C1 symmetry | Insulin receptor (E.C.2.7.10.1), Insulin receptor subunit alpha (E.C.2.7.10.1), Insulin A chain, Insulin B chain |
6CEB | P01308 | Insulin Receptor ectodomain in complex with two insulin molecules - C1 symmetry | Insulin receptor (E.C.2.7.10.1), Insulin receptor subunit alpha (E.C.2.7.10.1), Insulin A chain, Insulin B chain |
6CEB | P01318 | Insulin Receptor ectodomain in complex with two insulin molecules - C1 symmetry | Insulin receptor (E.C.2.7.10.1), Insulin receptor subunit alpha (E.C.2.7.10.1), Insulin A chain, Insulin B chain |
4OGA | P01308 | Insulin in complex with Site 1 of the human insulin receptor | |
4OGA | 4OGA | Insulin in complex with Site 1 of the human insulin receptor | |
4OGA | P06213 | Insulin in complex with Site 1 of the human insulin receptor | |
2HR7 | P06213 | Insulin receptor (domains 1-3) | |
5KQV | P01317 | Insulin receptor ectodomain construct comprising domains L1,CR,L2, FnIII-1 and alphaCT peptide in complex with bovine insulin and FAB 83-14 (REVISED STRUCTURE) | |
5KQV | 5KQV | Insulin receptor ectodomain construct comprising domains L1,CR,L2, FnIII-1 and alphaCT peptide in complex with bovine insulin and FAB 83-14 (REVISED STRUCTURE) | |
5KQV | P06213 | Insulin receptor ectodomain construct comprising domains L1,CR,L2, FnIII-1 and alphaCT peptide in complex with bovine insulin and FAB 83-14 (REVISED STRUCTURE) | |
3W12 | P01308 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alpha-CT peptide(704-719) and FAB 83-7 | |
3W12 | 3W12 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alpha-CT peptide(704-719) and FAB 83-7 | |
3W12 | P06213 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alpha-CT peptide(704-719) and FAB 83-7 | |
3W13 | P01308 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alphact peptide(693-719) and FAB 83-7 | |
3W13 | 3W13 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alphact peptide(693-719) and FAB 83-7 | |
3W13 | P06213 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alphact peptide(693-719) and FAB 83-7 | |
3W11 | P01308 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with human insulin, Alpha-CT peptide(704-719) and FAB 83-7 | |
3W11 | 3W11 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with human insulin, Alpha-CT peptide(704-719) and FAB 83-7 | |
3W11 | P06213 | Insulin receptor ectodomain construct comprising domains L1-CR in complex with human insulin, Alpha-CT peptide(704-719) and FAB 83-7 | |
7MD5 | P06213 | Insulin receptor ectodomain dimer complexed with two IRPA-9 partial agonists | |
7MD5 | P01308 | Insulin receptor ectodomain dimer complexed with two IRPA-9 partial agonists | |
5C97 | Q9UIQ6 | Insulin regulated aminopeptidase | |
7ZYF | Q9UIQ6 | Insulin regulated aminopeptidase (IRAP) in complex with a nanomolar alpha hydroxy beta amino acid based inhibitor. | |
8CGP | Q9UIQ6 | Insulin regulated aminopeptidase (IRAP) in complex with an allosteric aryl sulfonamide inhibitor | |
4XSS | P05019 | Insulin-like growth factor I in complex with site 1 of a hybrid insulin receptor / Type 1 insulin-like growth factor receptor | |
4XSS | P06213 | Insulin-like growth factor I in complex with site 1 of a hybrid insulin receptor / Type 1 insulin-like growth factor receptor | |
4XSS | 4XSS | Insulin-like growth factor I in complex with site 1 of a hybrid insulin receptor / Type 1 insulin-like growth factor receptor | |
8CGW | Q9UIQ6 | Insulin-regulated aminopeptidase (IRAP) in complex with an allosteric benzopyran-based inhibitor | |
6YDX | Q9UIQ6 | Insulin-regulated aminopeptidase complexed with a macrocyclic peptidic inhibitor | |
5FGN | E3D1H8 | Integral membrane protein lipooligosaccharide phosphoethanolamine transferase A (EptA) from Neisseria meningitidis | |
2VDO | P08514 | Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide, HHLGGAKQAGDV | INTEGRIN ALPHA-IIB, INTEGRIN BETA-3, FIBRINOGEN, GAMMA POLYPEPTIDE, MONOCLONAL ANTIBODY 10E5 HEAVY CHAIN, MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN |
2VDO | P05106 | Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide, HHLGGAKQAGDV | INTEGRIN ALPHA-IIB, INTEGRIN BETA-3, FIBRINOGEN, GAMMA POLYPEPTIDE, MONOCLONAL ANTIBODY 10E5 HEAVY CHAIN, MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN |
2VDO | Q53Y18 | Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide, HHLGGAKQAGDV | INTEGRIN ALPHA-IIB, INTEGRIN BETA-3, FIBRINOGEN, GAMMA POLYPEPTIDE, MONOCLONAL ANTIBODY 10E5 HEAVY CHAIN, MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN |
2VDO | 2VDO | Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide, HHLGGAKQAGDV | INTEGRIN ALPHA-IIB, INTEGRIN BETA-3, FIBRINOGEN, GAMMA POLYPEPTIDE, MONOCLONAL ANTIBODY 10E5 HEAVY CHAIN, MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN |
2VDP | P08514 | Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide,LGGAKQAGDV | INTEGRIN ALPHA-IIB, INTEGRIN BETA-3, FIBRINOGEN, MONOCLONAL ANTIBODY 10E5 HEAVY CHAIN, MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN |
2VDP | P05106 | Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide,LGGAKQAGDV | INTEGRIN ALPHA-IIB, INTEGRIN BETA-3, FIBRINOGEN, MONOCLONAL ANTIBODY 10E5 HEAVY CHAIN, MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN |
2VDP | Q53Y18 | Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide,LGGAKQAGDV | INTEGRIN ALPHA-IIB, INTEGRIN BETA-3, FIBRINOGEN, MONOCLONAL ANTIBODY 10E5 HEAVY CHAIN, MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024